IMATINIB
imatinib 100 mg capsule, 60
IMATINIB (10920R)
10920R
Manner of administration:Oral
Restriction
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - first-line therapy
Restriction
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - first-line therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 2 | DPMQ: $99.84 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||